Patient Compliance

The fellowship will provide training to help U.S. healthcare providers empower, educate and improve equitable access to PrEP among key populations.

The FDA has approved the Dexcom Stelo Glucose Biosensor System.

Fingolimod Capsules are indicated for the treatment of relapsing forms of multiple sclerosis.

EHSI agreed to plead guilty to a single strict liability misdemeanor misbranding violation of the Federal Food, Drug, and Cosmetic Act related to certain Opana ER marketing occurring between April 2012 and May 2013.

Brandon Faber, Director of Sales at Allison Medical, shares why the brand’s diabetes supplies are a staple amongst retailers and diabetes patients.

Pharmacy advocates will urge members of Congress to act on legislative priorities that benefit Americans and the pharmacies on which they rely.

Motpoly XR is approved for the treatment of partial-onset seizures in adults and in some pediatric patients.

The roundtable focused on anticompetitive PBM practices that drive up drug costs for American families, limit patient choice and squeeze community pharmacies.